WebThe present invention relates to a multi-specific antibody having specificity for human IL-13, human IL-17A and/or human IL-17F. The invention further relates to methods for producing the multi-specific antibody and to its therapeutic use for the treatment of atopic dermatitis and other diseases. WebMithramycin has been tested as a neuroprotector for Huntington’s disease and neuronal death [11,12]. Mechanistic studies proved that AA-derived antibiotics demonstrate a strong preference for GC-rich DNA sequences [13,14]. ... Subscribe to receive issue release notifications and newsletters from MDPI journals
Evaluation of mithramycin in the treatment of anaplastic gliomas
WebPage 1/7 Safety Data Sheet acc. to OSHA HCS Printing date 09/20/2024 Revision date 09/20/2024 53.1.21 * 1 Identification · Product identifier · Trade name:Mithramycin A · … WebInhibits DNA methyltransferase (ref 1). A selective Sp1 inhibitor, it binds to GC rich DNA sequences, displacing Sp1 transcription factor binding to oncogene promoters, inhibiting … expository essay about family
Mithramycin A CAS#:18378-89-7 Chemsrc
Web1 sep. 2024 · The aureolic acid-type polyketide mithramycin (MTM) has a remarkable cytotoxicity against a variety of human tumors and has been used for the treatment of … Web23 okt. 2024 · Herein, we show for the first time that mithramycin A (Mit-A) can successfully inhibit CSC proliferation, in addition to inhibiting bulk cancer cells in a model of colorectal … WebMithramycin; Plicamycine; Mithramycine; edit. Language Label Description Also known as; English: plicamycin. antibiotic isolated from the bacterium Streptomyces plicatus with antineoplastic activity. PA-144; A-2371; bubble tea twitter